- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
SMS Lifesciences India Limited — Board Meeting, 10-11-2025: Outcome of Board Meeting
10-11-2025 | 04:45 pm
10-11-2025 | 04:45 pm
Haleos Labs' board approved Q2/H1 FY26 consolidated financial results. Half-year revenue reached ₹163.87 Cr and Net Profit ₹10.81 Cr, with EPS at ₹33.93. The company confirmed its name change from SMS Lifesciences India.
No comments yet. Be the first to comment!